DORZOLAMIDE HYDROCHLORIDE

DORZOLAMIDE HYDROCHLORIDE was reported 7931 times

DORZOLAMIDE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IRIDODIALYSIS 2 0.4000
1 RETINOPATHY SICKLE CELL 2 0.1111
2 STEROID DEPENDENCE 78 0.0888
3 CATARRH 78 0.0863
4 CATATHRENIA 1 0.0769
5 BLEPHARORRHAPHY 1 0.0625
6 GLAUCOMATOUS OPTIC NEUROPATHY 1 0.0500
7 BURNS SECOND DEGREE 77 0.0438
8 EPIGLOTTIS DYSFUNCTION 1 0.0400
9 CONJUNCTIVAL FOLLICLES 1 0.0312
10 ALCOHOL POISONING 69 0.0257
11 CORNEAL IRRITATION 2 0.0250
12 ARTERIAL CATHETERISATION 2 0.0244
13 HYPOPNOEA 77 0.0222
14 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 8 0.0220
15 DIALYSIS HYPOTENSION 2 0.0202
16 BENIGN NEOPLASM OF EYE 1 0.0200
17 ANDROPAUSE 1 0.0192
18 ANTERIOR CHAMBER DISORDER 4 0.0174
19 THYMUS DISORDER 3 0.0157
20 INSTILLATION SITE DRYNESS 2 0.0155
21 DYSMETROPSIA 1 0.0154
22 HYPHAEMA 7 0.0134
23 BLADDER STENOSIS 1 0.0122
24 BRONCHIECTASIS 81 0.0120
25 HYPOTONY OF EYE 5 0.0119
26 BLOOD PROLACTIN DECREASED 2 0.0114
27 OCULAR SURFACE DISEASE 3 0.0107
28 PAROSMIA 77 0.0102
29 CHORIORETINAL DISORDER 2 0.0102
30 GINGIVAL PAIN 79 0.0099
31 CORNEAL OPERATION 1 0.0097
32 FUNDOSCOPY ABNORMAL 1 0.0096
33 RHINITIS 77 0.0095
34 MEAN PLATELET VOLUME DECREASED 8 0.0095
35 ABDOMINAL LYMPHADENOPATHY 8 0.0092
36 CARDIAC MURMUR 77 0.0089
37 CHOROIDAL EFFUSION 7 0.0087
38 EYELASH THICKENING 1 0.0083
39 CHOROIDAL INFARCTION 1 0.0083
40 BLEPHAROPLASTY 1 0.0082
41 RETINAL VASCULAR OCCLUSION 6 0.0081
42 INSTILLATION SITE PRURITUS 3 0.0080
43 GLAUCOMA SURGERY 2 0.0078
44 INSTILLATION SITE ERYTHEMA 4 0.0076
45 TUMOUR FLARE 5 0.0073
46 PRODUCT CONTAINER ISSUE 62 0.0072
47 AORTIC CALCIFICATION 4 0.0069
48 INSTILLATION SITE IRRITATION 8 0.0068
49 MONOCYTE COUNT DECREASED 8 0.0066
50 TRICHIASIS 2 0.0063
51 FIBROMUSCULAR DYSPLASIA 1 0.0061
52 PERIORBITAL PAIN 5 0.0059
53 PERIORBITAL IRRITATION 2 0.0058
54 EYELID BLEEDING 1 0.0058
55 LEIOMYOMA 4 0.0058
56 EYELASH CHANGES 1 0.0056
57 EYELID PAIN 11 0.0054
58 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 9 0.0054
59 CHOROIDAL HAEMORRHAGE 1 0.0052
60 CORNEAL TRANSPLANT 4 0.0051
61 EYE LASER SURGERY 3 0.0051
62 INTRAOCULAR PRESSURE INCREASED 64 0.0050
63 CATARACT SUBCAPSULAR 3 0.0049
64 RETINAL ISCHAEMIA 3 0.0049
65 CORNEAL GRAFT REJECTION 1 0.0048
66 IMPAIRED QUALITY OF LIFE 65 0.0045
67 CENTRAL VISION LOSS 1 0.0045
68 INSTILLATION SITE PAIN 11 0.0044
69 ANTERIOR CHAMBER FLARE 1 0.0043
70 PRODUCT AFTER TASTE 4 0.0042
71 EUSTACHIAN TUBE DISORDER 1 0.0042
72 TYPE V HYPERLIPIDAEMIA 2 0.0041
73 ENTEROBACTER TEST POSITIVE 1 0.0041
74 TUBULOINTERSTITIAL NEPHRITIS 76 0.0041
75 CORNEAL THINNING 1 0.0039
76 EYELID CYST 1 0.0039
77 DEVICE WIRELESS COMMUNICATION ISSUE 1 0.0039
78 INJURY CORNEAL 2 0.0038
79 HYPERHOMOCYSTEINAEMIA 1 0.0038
80 EYE COMPLICATION ASSOCIATED WITH DEVICE 1 0.0037
81 REACTION TO PRESERVATIVES 3 0.0037
82 SUPERFICIAL INJURY OF EYE 4 0.0037
83 IMPAIRED WORK ABILITY 78 0.0036
84 CHOROIDAL DETACHMENT 2 0.0036
85 ECZEMA EYELIDS 2 0.0036
86 DAIRY INTOLERANCE 1 0.0036
87 COMPLICATION OF DELIVERY 1 0.0035
88 ENDOCRINE OPHTHALMOPATHY 3 0.0035
89 HEART FAILURE WITH PRESERVED EJECTION FRACTION 1 0.0034
90 EAR TUBE INSERTION 1 0.0034
91 SPONDYLOARTHROPATHY 2 0.0033
92 CORNEA VERTICILLATA 1 0.0033
93 OPEN ANGLE GLAUCOMA 2 0.0033
94 CORNEAL LESION 1 0.0032
95 PRODUCT DEPOSIT 5 0.0032
96 FOREIGN BODY IN EYE 3 0.0031
97 EYE INFECTION VIRAL 1 0.0031
98 GINGIVAL DISCOMFORT 2 0.0030
99 ECTROPION 1 0.0030
100 FREQUENT BOWEL MOVEMENTS 80 0.0030
101 MACULAR FIBROSIS 2 0.0029
102 INTRAOCULAR PRESSURE TEST ABNORMAL 2 0.0028
103 PRODUCT DESIGN ISSUE 2 0.0028
104 IMMUNISATION REACTION 2 0.0028
105 ADENOIDAL HYPERTROPHY 1 0.0026
106 CHROMATOPSIA 2 0.0026
107 EYE PAIN 144 0.0025
108 PRODUCT DROPPER ISSUE 2 0.0025
109 GROWTH OF EYELASHES 2 0.0025
110 SWOLLEN TONGUE 78 0.0025
111 DEVICE COLOUR ISSUE 1 0.0025
112 EYE IRRITATION 141 0.0024
113 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 2 0.0024
114 EYELID MARGIN CRUSTING 7 0.0024
115 CORNEAL DYSTROPHY 1 0.0024
116 EYELID IRRITATION 6 0.0024
117 AUTOIMMUNE THROMBOCYTOPENIA 1 0.0023
118 GINGIVAL BLISTER 1 0.0023
119 GLAUCOMA 44 0.0023
120 ACCIDENTAL OVERDOSE 83 0.0023
121 NIGHTMARE 78 0.0023
122 PRODUCT DELIVERY MECHANISM ISSUE 12 0.0022
123 OCULAR DISCOMFORT 25 0.0022
124 SYSTEMIC LUPUS ERYTHEMATOSUS 79 0.0022
125 ERYTHEMA OF EYELID 12 0.0022
126 ANAEMIA OF CHRONIC DISEASE 2 0.0022
127 FOREIGN BODY SENSATION IN EYES 14 0.0022
128 ANTI-THYROID ANTIBODY POSITIVE 1 0.0022
129 GASTRIC VARICES 1 0.0021
130 DISCOLOURED VOMIT 2 0.0021
131 RECTAL HAEMORRHAGE 89 0.0021
132 OCULAR HYPERTENSION 4 0.0021
133 BLEPHARITIS 8 0.0020
134 PRODUCT CLOSURE REMOVAL DIFFICULT 2 0.0020
135 EYE OPERATION 9 0.0020
136 CONJUNCTIVAL OEDEMA 2 0.0019
137 EYE ALLERGY 3 0.0019
138 RED CELL DISTRIBUTION WIDTH INCREASED 8 0.0019
139 ABDOMINAL INJURY 1 0.0019
140 SWELLING OF EYELID 12 0.0019
141 ANAL STENOSIS 1 0.0019
142 ALBUMINURIA 1 0.0019
143 FRACTURE PAIN 1 0.0019
144 CORNEAL EROSION 1 0.0019
145 TINNITUS 85 0.0018
146 TREATMENT FAILURE 152 0.0018
147 COLITIS ULCERATIVE 80 0.0018
148 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 85 0.0018
149 DUODENAL ULCER HAEMORRHAGE 5 0.0017
150 BURN ORAL CAVITY 1 0.0017
151 EYELID DISORDER 4 0.0017
152 PRODUCT CONTAINER SEAL ISSUE 3 0.0017
153 CELLULITIS ORBITAL 1 0.0017
154 EYE BURNS 1 0.0017
155 HYPOAESTHESIA EYE 1 0.0017
156 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
157 HAND DEFORMITY 22 0.0017
158 DRUG MONITORING PROCEDURE NOT PERFORMED 3 0.0017
159 ABNORMAL SENSATION IN EYE 7 0.0016
160 HELICOBACTER GASTRITIS 2 0.0016
161 CYSTOID MACULAR OEDEMA 3 0.0016
162 ARTERITIS 1 0.0016
163 RETINAL OEDEMA 3 0.0016
164 SCIATICA 25 0.0016
165 ECZEMA 82 0.0016
166 ANAL INFLAMMATION 1 0.0016
167 OCULAR HYPERAEMIA 74 0.0016
168 ENTEROCOCCUS TEST POSITIVE 1 0.0015
169 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
170 LIQUID PRODUCT PHYSICAL ISSUE 11 0.0015
171 MEDICATION ERROR 82 0.0015
172 HAEMATOCHEZIA 81 0.0015
173 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
174 IMMUNOGLOBULINS DECREASED 2 0.0015
175 EYE DISCHARGE 15 0.0014
176 CRANIAL NERVE DISORDER 1 0.0014
177 OPTIC NEUROPATHY 3 0.0014
178 PERIORBITAL SWELLING 8 0.0014
179 CONJUNCTIVAL HYPERAEMIA 5 0.0014
180 ANTERIOR CHAMBER CELL 1 0.0014
181 DENTAL RESTORATION FAILURE 1 0.0014
182 VERTIGO 83 0.0014
183 CORNEAL DEPOSITS 1 0.0013
184 DEEP VEIN THROMBOSIS 86 0.0013
185 ASTIGMATISM 2 0.0013
186 BRONCHIAL DISORDER 2 0.0013
187 DRUG TOLERANCE INCREASED 1 0.0013
188 BLISTER INFECTED 1 0.0013
189 INFUSION SITE PRURITUS 4 0.0013
190 AORTIC DISORDER 1 0.0013
191 EYELID EXFOLIATION 1 0.0013
192 KERATOPATHY 2 0.0013
193 INCORRECT DOSE ADMINISTERED BY PRODUCT 2 0.0012
194 CARTILAGE ATROPHY 1 0.0012
195 DYSGEUSIA 92 0.0012
196 EYE PRURITUS 41 0.0012
197 RETINAL TEAR 3 0.0012
198 CIRCADIAN RHYTHM SLEEP DISORDER 1 0.0012
199 DYSCHROMATOPSIA 1 0.0012
200 COVID-19 IMMUNISATION 1 0.0012
201 ENZYME LEVEL INCREASED 1 0.0012
202 ANGLE CLOSURE GLAUCOMA 3 0.0012
203 DERMATITIS EXFOLIATIVE GENERALISED 4 0.0011
204 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
205 ENTEROCUTANEOUS FISTULA 1 0.0011
206 VENOUS OCCLUSION 2 0.0011
207 ULCERATIVE KERATITIS 3 0.0011
208 UTERINE LEIOMYOMA 8 0.0011
209 ESSENTIAL HYPERTENSION 2 0.0011
210 SINUS NODE DYSFUNCTION 2 0.0011
211 METAMORPHOPSIA 2 0.0011
212 PRODUCT USE COMPLAINT 17 0.0011
213 BONE GRAFT 1 0.0011
214 BLOOD IRON INCREASED 2 0.0011
215 EYE INFLAMMATION 10 0.0010
216 ARTHRITIS 82 0.0010
217 OESOPHAGEAL ULCER 4 0.0010
218 COLON NEOPLASM 1 0.0010
219 INTENTIONAL PRODUCT USE ISSUE 90 0.0010
220 WRONG PATIENT RECEIVED PRODUCT 3 0.0010
221 EYELID RASH 1 0.0010
222 VITREOUS FLOATERS 10 0.0010
223 HYPERVOLAEMIA 5 0.0010
224 CATARACT OPERATION 6 0.0010
225 PHOTOPHOBIA 19 0.0010
226 CARDIAC ANEURYSM 1 0.0010
227 HIGH DENSITY LIPOPROTEIN INCREASED 1 0.0010
228 IRITIS 3 0.0010
229 KERATITIS 3 0.0010
230 EYE COLOUR CHANGE 1 0.0010
231 DEFORMITY 9 0.0010
232 IRIDOCYCLITIS 3 0.0009
233 VASCULAR OCCLUSION 2 0.0009
234 EYE CONTUSION 2 0.0009
235 ALLERGY TO ANIMAL 1 0.0009
236 ANAEMIA MACROCYTIC 2 0.0009
237 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
238 VITREOUS DETACHMENT 2 0.0009
239 EYE INFECTION 10 0.0009
240 MIGRAINE 84 0.0009
241 NEUTROPHIL COUNT INCREASED 9 0.0009
242 CARBON DIOXIDE DECREASED 1 0.0009
243 BLINDNESS UNILATERAL 12 0.0008
244 DEVICE DISPENSING ERROR 1 0.0008
245 PULMONARY EMBOLISM 79 0.0008
246 VISUAL FIELD DEFECT 6 0.0008
247 LACRIMATION INCREASED 25 0.0008
248 WRONG DOSE 2 0.0008
249 EYELID SKIN DRYNESS 1 0.0008
250 CARDIAC DYSFUNCTION 3 0.0008
251 APPLICATION SITE SCAR 1 0.0008
252 PALPITATIONS 93 0.0008
253 PHOTOPSIA 5 0.0008
254 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
255 GLUCOSE URINE PRESENT 1 0.0008
256 BLOOD CREATINE PHOSPHOKINASE MB INCREASED 1 0.0008
257 ADVERSE DRUG REACTION 70 0.0008
258 EYE SWELLING 28 0.0008
259 PRODUCT RESIDUE PRESENT 4 0.0007
260 INTERNATIONAL NORMALISED RATIO DECREASED 3 0.0007
261 RECURRENT CANCER 3 0.0007
262 CORNEAL OPACITY 1 0.0007
263 EFFUSION 1 0.0007
264 VITREOUS HAEMORRHAGE 2 0.0007
265 APPLICATION SITE INFLAMMATION 1 0.0007
266 PRODUCT LEAKAGE 4 0.0007
267 AUDITORY DISORDER 1 0.0007
268 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
269 RETINAL VEIN OCCLUSION 2 0.0007
270 HORDEOLUM 3 0.0007
271 PLATELET COUNT INCREASED 9 0.0007
272 DARK CIRCLES UNDER EYES 1 0.0007
273 EXCESSIVE EYE BLINKING 1 0.0007
274 CONJUNCTIVITIS ALLERGIC 1 0.0007
275 APRAXIA 1 0.0007
276 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
277 EYE INJURY 2 0.0007
278 GENITAL HERPES 1 0.0007
279 PRESCRIBED UNDERDOSE 13 0.0007
280 SYNOVIAL CYST 3 0.0006
281 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
282 COAGULATION TIME PROLONGED 1 0.0006
283 PELVIC FRACTURE 5 0.0006
284 EYELIDS PRURITUS 2 0.0006
285 NASAL DRYNESS 4 0.0006
286 GASTROINTESTINAL STOMA COMPLICATION 1 0.0006
287 SKIN ABRASION 3 0.0006
288 COLITIS MICROSCOPIC 3 0.0006
289 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 114 0.0006
290 CYSTITIS INTERSTITIAL 1 0.0006
291 CARDIOVASCULAR INSUFFICIENCY 1 0.0006
292 DEAFNESS NEUROSENSORY 2 0.0006
293 HAEMATOCRIT DECREASED 12 0.0006
294 GASTRIC DILATATION 1 0.0006
295 PRODUCT ADMINISTRATION ERROR 12 0.0006
296 THROMBOPHLEBITIS 2 0.0006
297 BREAST CYST 1 0.0006
298 VISION BLURRED 77 0.0006
299 ISCHAEMIC STROKE 10 0.0006
300 ABDOMINAL DISCOMFORT 93 0.0006
301 DEVICE ALARM ISSUE 1 0.0006
302 CONFUSIONAL STATE 89 0.0006
303 HEPATIC CYTOLYSIS 7 0.0005
304 ASTHENOPIA 3 0.0005
305 BLINDNESS TRANSIENT 4 0.0005
306 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
307 DRY EYE 27 0.0005
308 CATHETER PLACEMENT 1 0.0005
309 TENDON INJURY 2 0.0005
310 MACULAR OEDEMA 3 0.0005
311 HYPERTENSIVE HEART DISEASE 1 0.0005
312 MULTIPLE USE OF SINGLE-USE PRODUCT 3 0.0005
313 THROAT CLEARING 2 0.0005
314 ARTERIOSCLEROSIS 5 0.0005
315 COVID-19 93 0.0005
316 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
317 HYPERCOAGULATION 1 0.0005
318 PARANASAL SINUS HYPERSECRETION 2 0.0005
319 CEREBROVASCULAR ACCIDENT 88 0.0005
320 UVEITIS 7 0.0005
321 ALCOHOL INTERACTION 1 0.0005
322 VISUAL ACUITY REDUCED 17 0.0005
323 HYPERAEMIA 1 0.0005
324 SINUS HEADACHE 3 0.0005
325 DEVICE RELATED SEPSIS 1 0.0005
326 SPINAL FUSION SURGERY 2 0.0005
327 BREAST DISORDER 1 0.0005
328 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
329 HYPERPARATHYROIDISM 1 0.0005
330 PRODUCT AVAILABILITY ISSUE 11 0.0005
331 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
332 INFUSION SITE ERYTHEMA 4 0.0005
333 DEVICE CONNECTION ISSUE 1 0.0005
334 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
335 HAEMORRHAGE INTRACRANIAL 7 0.0005
336 BLINDNESS 19 0.0005
337 DEVICE OPERATIONAL ISSUE 2 0.0005
338 EXOPHTHALMOS 1 0.0005
339 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
340 TOXIC EPIDERMAL NECROLYSIS 7 0.0005
341 SKIN LACERATION 5 0.0005
342 CORNEAL DISORDER 1 0.0005
343 DIABETIC NEPHROPATHY 1 0.0005
344 LYMPHOCYTE COUNT DECREASED 8 0.0005
345 PHYSICAL DISABILITY 2 0.0005
346 DANDRUFF 1 0.0005
347 SOMNOLENCE 91 0.0005
348 EYE HAEMORRHAGE 6 0.0004
349 CORNEAL OEDEMA 1 0.0004
350 FEAR OF DEATH 1 0.0004
351 BLOOD LOSS ANAEMIA 1 0.0004
352 VASCULAR DEVICE INFECTION 2 0.0004
353 BLOOD THYROID STIMULATING HORMONE DECREASED 2 0.0004
354 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
355 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
356 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
357 EYELID OEDEMA 5 0.0004
358 ROSACEA 2 0.0004
359 ESCHERICHIA BACTERAEMIA 1 0.0004
360 SARCOIDOSIS 2 0.0004
361 MACULAR DEGENERATION 5 0.0004
362 PRODUCT USE IN UNAPPROVED INDICATION 103 0.0004
363 VISUAL IMPAIRMENT 51 0.0004
364 CIRCULATORY COLLAPSE 7 0.0004
365 EYE OEDEMA 1 0.0004
366 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
367 CARTILAGE INJURY 1 0.0004
368 PRODUCT DOSE OMISSION ISSUE 119 0.0004
369 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
370 CONDITION AGGRAVATED 123 0.0004
371 CATARACT 24 0.0004
372 HYPERPARATHYROIDISM SECONDARY 1 0.0004
373 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
374 BRAIN ABSCESS 1 0.0004
375 ENDODONTIC PROCEDURE 1 0.0004
376 BLOOD PRESSURE DIASTOLIC ABNORMAL 1 0.0004
377 DIABETIC COMPLICATION 1 0.0004
378 BOWEL MOVEMENT IRREGULARITY 3 0.0004
379 CANCER PAIN 1 0.0004
380 DISSEMINATED TUBERCULOSIS 1 0.0004
381 PRODUCT COLOUR ISSUE 2 0.0004
382 RIB FRACTURE 8 0.0004
383 VARICOSE VEIN 2 0.0004
384 CATHETER SITE PAIN 1 0.0004
385 PERIORBITAL OEDEMA 2 0.0004
386 RED BLOOD CELL COUNT DECREASED 11 0.0004
387 WEIGHT DECREASED 107 0.0004
388 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
389 HYPERSENSITIVITY VASCULITIS 1 0.0004
390 DEPRESSION 85 0.0004
391 INJECTION SITE DISCHARGE 2 0.0004
392 CHEILITIS 2 0.0004
393 CHONDROPATHY 1 0.0004
394 CHOLESTASIS 7 0.0004
395 ABNORMAL DREAMS 10 0.0004
396 PAIN IN EXTREMITY 106 0.0004
397 DIABETIC COMA 1 0.0004
398 DRUG TOLERANCE DECREASED 1 0.0004
399 PRODUCT QUALITY ISSUE 48 0.0004
400 SEASONAL ALLERGY 5 0.0004
401 CEREBRAL THROMBOSIS 1 0.0004
402 SCAB 4 0.0004
403 EXPOSURE VIA SKIN CONTACT 9 0.0003
404 HYPERTONIC BLADDER 1 0.0003
405 DYSPNOEA EXERTIONAL 13 0.0003
406 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
407 PURPURA 3 0.0003
408 BACTERAEMIA 4 0.0003
409 CARDIAC PACEMAKER INSERTION 2 0.0003
410 INJECTION SITE REACTION 23 0.0003
411 OROPHARYNGEAL DISCOMFORT 3 0.0003
412 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
413 NOCTURIA 4 0.0003
414 RETINAL DETACHMENT 3 0.0003
415 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
416 THYROID DISORDER 5 0.0003
417 PIGMENTATION DISORDER 2 0.0003
418 CONJUNCTIVITIS 6 0.0003
419 PRODUCT DISTRIBUTION ISSUE 3 0.0003
420 BRAIN FOG 5 0.0003
421 DRUG EFFECT INCREASED 1 0.0003
422 PRODUCT PACKAGING ISSUE 3 0.0003
423 BREAST ENLARGEMENT 1 0.0003
424 C-REACTIVE PROTEIN INCREASED 11 0.0003
425 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
426 APPETITE DISORDER 2 0.0003
427 HIGH DENSITY LIPOPROTEIN DECREASED 1 0.0003
428 WRONG PRODUCT ADMINISTERED 2 0.0003
429 TASTE DISORDER 6 0.0003
430 DRY THROAT 3 0.0003
431 PRODUCT LABEL ISSUE 2 0.0003
432 DIABETIC RETINOPATHY 1 0.0003
433 BRONCHOPNEUMONIA 1 0.0003
434 ONYCHOCLASIS 2 0.0003
435 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
436 HAIR GROWTH ABNORMAL 2 0.0003
437 DEPRESSION SUICIDAL 1 0.0003
438 PETECHIAE 3 0.0003
439 CAROTID ARTERY STENOSIS 1 0.0003
440 RIGHT VENTRICULAR FAILURE 2 0.0003
441 ERYTHEMA NODOSUM 1 0.0003
442 HEART RATE DECREASED 10 0.0003
443 HEAD DISCOMFORT 5 0.0003
444 DIALYSIS 4 0.0003
445 GLOSSITIS 1 0.0003
446 RETINAL HAEMORRHAGE 2 0.0003
447 APPENDICECTOMY 1 0.0003
448 SYNOVITIS 5 0.0003
449 OESOPHAGITIS 3 0.0003
450 ARRHYTHMIA 13 0.0003
451 PRODUCT STORAGE ERROR 24 0.0003
452 CUTANEOUS VASCULITIS 1 0.0003
453 ASTHMATIC CRISIS 1 0.0003
454 EYE DISORDER 9 0.0003
455 BLOOD PHOSPHORUS DECREASED 1 0.0003
456 SENSITIVE SKIN 2 0.0003
457 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
458 FREEZING PHENOMENON 1 0.0003
459 HYPERSENSITIVITY 50 0.0003
460 HYPERACUSIS 1 0.0003
461 CHRONIC SINUSITIS 1 0.0003
462 OSTEOPENIA 4 0.0003
463 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
464 LIPASE INCREASED 2 0.0003
465 CONCUSSION 2 0.0003
466 BLOOD CHOLESTEROL INCREASED 12 0.0003
467 CARDIOPULMONARY FAILURE 1 0.0003
468 MULTIPLE ALLERGIES 2 0.0003
469 PYREXIA 88 0.0003
470 COVID-19 PNEUMONIA 3 0.0003
471 NO ADVERSE EVENT 46 0.0003
472 RESPIRATORY TRACT CONGESTION 4 0.0003
473 TRICUSPID VALVE INCOMPETENCE 2 0.0003
474 MYOCLONUS 3 0.0003
475 BLOOD PRESSURE ABNORMAL 5 0.0003
476 PRODUCTIVE COUGH 12 0.0003
477 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
478 FUNGAL SKIN INFECTION 1 0.0002
479 ENURESIS 1 0.0002
480 RASH 107 0.0002
481 HICCUPS 2 0.0002
482 HYPERCALCAEMIA 3 0.0002
483 SENSATION OF FOREIGN BODY 2 0.0002
484 HALLUCINATION, VISUAL 5 0.0002
485 MOBILITY DECREASED 17 0.0002
486 VITAMIN D DECREASED 2 0.0002
487 INFUSION SITE PAIN 3 0.0002
488 DEAFNESS 6 0.0002
489 DEVICE USE ISSUE 4 0.0002
490 PULMONARY CONGESTION 3 0.0002
491 PRODUCT COMMUNICATION ISSUE 2 0.0002
492 BRADYCARDIA 12 0.0002
493 FACIAL PAIN 2 0.0002
494 SINUS CONGESTION 3 0.0002
495 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
496 GINGIVAL BLEEDING 3 0.0002
497 HAEMOGLOBIN INCREASED 1 0.0002
498 PERIPHERAL COLDNESS 3 0.0002
499 DISEASE COMPLICATION 1 0.0002
500 EAR DISORDER 1 0.0002
501 INCREASED TENDENCY TO BRUISE 2 0.0002
502 MUSCLE TWITCHING 5 0.0002
503 UROSEPSIS 2 0.0002
504 LACTIC ACIDOSIS 7 0.0002
505 ORAL DISCOMFORT 3 0.0002
506 PAIN 132 0.0002
507 BURNING SENSATION 15 0.0002
508 BLISTER 12 0.0002
509 SKIN REACTION 3 0.0002
510 HEADACHE 133 0.0002
511 RHEUMATOID ARTHRITIS 24 0.0002
512 SPINAL DISORDER 2 0.0002
513 INTENTIONAL DOSE OMISSION 6 0.0002
514 PRODUCT PRESCRIBING ERROR 5 0.0002
515 BLOOD PRESSURE FLUCTUATION 5 0.0002
516 HORMONE LEVEL ABNORMAL 1 0.0002
517 SKIN FISSURES 4 0.0002
518 PHARYNGEAL SWELLING 2 0.0002
519 SKIN HAEMORRHAGE 3 0.0002
520 DIABETIC NEUROPATHY 1 0.0002
521 INABILITY TO AFFORD MEDICATION 2 0.0002
522 AGEUSIA 5 0.0002
523 FLUID INTAKE REDUCED 1 0.0002
524 HYPOAESTHESIA ORAL 3 0.0002
525 EMPHYSEMA 2 0.0002
526 DYSLIPIDAEMIA 1 0.0002
527 EYELID PTOSIS 2 0.0002
528 FATIGUE 153 0.0002
529 INSURANCE ISSUE 3 0.0002
530 SLUGGISHNESS 2 0.0002
531 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
532 FEMORAL NECK FRACTURE 1 0.0002
533 HELICOBACTER INFECTION 2 0.0002
534 GAIT DISTURBANCE 37 0.0002
535 PRODUCT ODOUR ABNORMAL 2 0.0002
536 TRANSFUSION 2 0.0002
537 GASTRITIS 5 0.0002
538 FULL BLOOD COUNT ABNORMAL 2 0.0002
539 RENAL PAIN 2 0.0002
540 EAR INFECTION 5 0.0002
541 NASAL CONGESTION 11 0.0002
542 EPISTAXIS 14 0.0002
543 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
544 HYPOGLYCAEMIA 9 0.0002
545 DECREASED ACTIVITY 2 0.0002
546 HIP SURGERY 1 0.0002
547 OFF LABEL USE 161 0.0002
548 HYDROCEPHALUS 1 0.0002
549 FAECALOMA 1 0.0002
550 COUGH 51 0.0002
551 DEAFNESS UNILATERAL 1 0.0002
552 LEUKOPENIA 9 0.0002
553 HEART RATE ABNORMAL 1 0.0002
554 ORAL PAIN 4 0.0002
555 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
556 GRANULOCYTOPENIA 1 0.0002
557 MICTURITION URGENCY 2 0.0002
558 CHOLECYSTECTOMY 2 0.0002
559 CARDIAC VALVE DISEASE 1 0.0002
560 MUSCULOSKELETAL DISCOMFORT 3 0.0002
561 GASTROOESOPHAGEAL REFLUX DISEASE 14 0.0002
562 BLOOD URIC ACID INCREASED 1 0.0002
563 EXTRA DOSE ADMINISTERED 7 0.0002
564 ACUTE KIDNEY INJURY 26 0.0002
565 BRADYKINESIA 1 0.0002
566 HYPERLIPIDAEMIA 2 0.0002
567 POLYNEUROPATHY 2 0.0002
568 ENDOPHTHALMITIS 1 0.0002
569 GANGRENE 1 0.0002
570 BLOOD PRESSURE DECREASED 11 0.0002
571 MENTAL IMPAIRMENT 4 0.0002
572 DRUG INEFFECTIVE 217 0.0002
573 PANIC ATTACK 6 0.0002
574 FOETAL GROWTH RESTRICTION 1 0.0002
575 CYTOPENIA 2 0.0002
576 BRONCHITIS 12 0.0002
577 HEART RATE INCREASED 16 0.0002
578 BACTERIAL INFECTION 3 0.0002
579 APPLICATION SITE IRRITATION 2 0.0002
580 SECRETION DISCHARGE 2 0.0002
581 BLOOD SODIUM DECREASED 3 0.0002
582 DERMATITIS ALLERGIC 2 0.0002
583 PRODUCT COMPLAINT 4 0.0002
584 GASTRIC ULCER 3 0.0002
585 FLUID RETENTION 8 0.0002
586 CYSTITIS 5 0.0002
587 HYPOPHAGIA 4 0.0002
588 ENTERITIS 1 0.0002
589 THROAT IRRITATION 7 0.0002
590 MYDRIASIS 2 0.0002
591 DRUG INTOLERANCE 15 0.0002
592 DIPLOPIA 4 0.0002
593 NERVOUSNESS 8 0.0002
594 TOOTH INFECTION 2 0.0002
595 SARS-COV-2 TEST POSITIVE 2 0.0002
596 BALANCE DISORDER 13 0.0002
597 GAIT INABILITY 5 0.0001
598 BREAST MASS 1 0.0001
599 FULL BLOOD COUNT DECREASED 3 0.0001
600 COLITIS ISCHAEMIC 1 0.0001
601 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
602 PRODUCT TASTE ABNORMAL 2 0.0001
603 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
604 PALLOR 4 0.0001
605 HAEMOGLOBIN DECREASED 15 0.0001
606 EYE MOVEMENT DISORDER 1 0.0001
607 ECCHYMOSIS 1 0.0001
608 DIVERTICULITIS 4 0.0001
609 PULMONARY HYPERTENSION 3 0.0001
610 AUTOIMMUNE HEPATITIS 1 0.0001
611 FEELING COLD 4 0.0001
612 HYPOMAGNESAEMIA 2 0.0001
613 EXTRASYSTOLES 1 0.0001
614 WOUND 4 0.0001
615 DEFAECATION URGENCY 1 0.0001
616 HAND FRACTURE 1 0.0001
617 THERAPY INTERRUPTED 10 0.0001
618 HYPERSOMNIA 4 0.0001
619 PRURITUS GENERALISED 3 0.0001
620 PRODUCT USE ISSUE 26 0.0001
621 DERMATITIS BULLOUS 1 0.0001
622 FAECES SOFT 1 0.0001
623 GASTROENTERITIS 2 0.0001
624 DYSSTASIA 4 0.0001
625 MELAENA 3 0.0001
626 DRY MOUTH 11 0.0001
627 CARDIOMYOPATHY 2 0.0001
628 FEELING DRUNK 1 0.0001
629 PULMONARY MASS 2 0.0001
630 BREAST TENDERNESS 1 0.0001
631 HOT FLUSH 10 0.0001
632 DEPRESSED MOOD 7 0.0001
633 ECONOMIC PROBLEM 2 0.0001
634 DEVICE FAILURE 2 0.0001
635 DISCOMFORT 8 0.0001
636 DRUG DISPENSING ERROR 2 0.0001
637 SKIN DISCOLOURATION 6 0.0001
638 FOOD ALLERGY 1 0.0001
639 ATRIOVENTRICULAR BLOCK 1 0.0001
640 DYSPNOEA 73 0.0001
641 DELUSION 2 0.0001
642 HAEMORRHAGIC STROKE 1 0.0001
643 CYANOSIS 2 0.0001
644 DIZZINESS 63 0.0001
645 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
646 DISORIENTATION 5 0.0001
647 BLOOD ALBUMIN DECREASED 1 0.0001
648 HIP FRACTURE 4 0.0001
649 BLOOD PRESSURE INCREASED 19 0.0001
650 LOCALISED INFECTION 3 0.0001
651 MUSCLE TIGHTNESS 2 0.0001
652 NEURALGIA 3 0.0001
653 DYSKINESIA 5 0.0001
654 DYSPEPSIA 12 0.0001
655 ACUTE CORONARY SYNDROME 1 0.0001
656 INFUSION RELATED REACTION 8 0.0001
657 SYNCOPE 12 0.0001
658 DYSPHONIA 7 0.0001
659 SURGERY 7 0.0001
660 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
661 SKIN EXFOLIATION 10 0.0001
662 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
663 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
664 CARDIAC OPERATION 1 0.0001
665 ORTHOSTATIC HYPOTENSION 2 0.0001
666 INTENTIONAL PRODUCT MISUSE 10 0.0001
667 HYPERKALAEMIA 4 0.0001
668 GRIP STRENGTH DECREASED 1 0.0001
669 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
670 MYALGIA 19 0.0001
671 PULMONARY OEDEMA 5 0.0001
672 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
673 HAEMOLYTIC ANAEMIA 1 0.0001
674 FEAR 3 0.0001
675 GOUT 2 0.0001
676 THROAT TIGHTNESS 3 0.0001
677 LIMB INJURY 3 0.0001
678 MOOD ALTERED 3 0.0001
679 RESTLESS LEGS SYNDROME 2 0.0001
680 EXOSTOSIS 1 0.0001
681 SKIN IRRITATION 5 0.0001
682 MUSCLE SPASMS 20 0.0001
683 HYPERTENSION 23 0.0001
684 RHINORRHOEA 7 0.0001
685 RENAL DISORDER 5 0.0001
686 MIDDLE INSOMNIA 2 0.0001
687 OXYGEN SATURATION DECREASED 6 0.0001
688 PAIN IN JAW 3 0.0001
689 HYPOCALCAEMIA 2 0.0001
690 FRACTURE 2 0.0001
691 MUSCULAR WEAKNESS 12 0.0001
692 URINARY TRACT INFECTION 18 0.0001
693 HAEMORRHAGE 11 0.0001
694 MUSCULOSKELETAL DISORDER 2 0.0001
695 SLEEP APNOEA SYNDROME 2 0.0001
696 HYPOTENSION 21 0.0001
697 PRODUCT SUBSTITUTION ISSUE 6 0.0001
698 PERIPHERAL SWELLING 16 0.0001
699 ERUCTATION 2 0.0001
700 PRESCRIBED OVERDOSE 2 0.0001
701 DECREASED APPETITE 24 0.0001
702 MALAISE 45 0.0001
703 HAEMORRHOIDS 2 0.0001
704 KIDNEY INFECTION 2 0.0001
705 MEMORY IMPAIRMENT 14 0.0001
706 HOSPICE CARE 1 0.0001
707 WHEEZING 6 0.0001
708 DISABILITY 2 0.0001
709 SINUS DISORDER 2 0.0001
710 ABNORMAL BEHAVIOUR 4 0.0001
711 CELLULITIS 5 0.0001
712 PRODUCT PHYSICAL ISSUE 2 0.0001
713 OEDEMA PERIPHERAL 12 0.0001
714 BODY TEMPERATURE INCREASED 2 0.0001
715 ADVERSE EVENT 9 0.0001
716 SINUSITIS 10 0.0001
717 EAR DISCOMFORT 1 0.0001
718 CONSTIPATION 21 0.0001
719 FALL 32 0.0001
720 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
721 DERMATITIS 2 0.0001
722 SPEECH DISORDER 5 0.0001
723 DRUG INTERACTION 15 0.0001
724 EATING DISORDER 2 0.0001
725 RETCHING 2 0.0001
726 BREAST PAIN 1 0.0001
727 LOSS OF CONSCIOUSNESS 12 0.0001
728 SKIN CANCER 2 0.0001
729 PNEUMONIA 30 0.0001
730 ERYTHEMA 19 0.0001
731 FAECES DISCOLOURED 2 0.0001
732 BIPOLAR DISORDER 1 0.0001
733 PRODUCT DISPENSING ERROR 2 0.0001
734 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
735 TREATMENT NONCOMPLIANCE 5 0.0001
736 PRURITUS 35 0.0001
737 APPLICATION SITE PAIN 2 0.0001
738 EXPIRED PRODUCT ADMINISTERED 3 0.0001
739 FOOT DEFORMITY 1 0.0001
740 LIP SWELLING 3 0.0001
741 RASH MACULO-PAPULAR 2 0.0001
742 HYPERTENSIVE CRISIS 1 0.0001
743 NECK PAIN 5 0.0001
744 GLOSSODYNIA 2 0.0001
745 RASH PAPULAR 2 0.0001
746 SNEEZING 2 0.0001
747 THERAPY NON-RESPONDER 4 0.0001
748 FISTULA 1 0.0001
749 CHROMATURIA 2 0.0001
750 HEART RATE IRREGULAR 2 0.0001
751 DERMATITIS CONTACT 1 0.0001
752 NEPHROLITHIASIS 4 0.0001
753 NASOPHARYNGITIS 16 0.0001
754 CHEST PAIN 16 0.0001
755 CAESAREAN SECTION 1 0.0001
756 RASH MACULAR 3 0.0001
757 ASTHENIA 32 0.0001
758 ATAXIA 1 0.0001
759 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
760 SKIN BURNING SENSATION 6 0.0001
761 STOMATITIS 5 0.0001
762 BURSITIS 1 0.0001
763 ADRENAL INSUFFICIENCY 1 0.0001
764 FIBROMYALGIA 2 0.0001
765 PRESYNCOPE 2 0.0001
766 ABASIA 2 0.0001
767 CYST 1 0.0001
768 HYPOAESTHESIA 12 0.0001
769 ABDOMINAL PAIN LOWER 2 0.0001
770 CHRONIC KIDNEY DISEASE 6 0.0001
771 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
772 ERECTILE DYSFUNCTION 2 0.0001
773 HIATUS HERNIA 1 0.0001
774 RASH GENERALISED 2 0.0001
775 HAEMATOMA 2 0.0001
776 RESPIRATORY TRACT INFECTION 2 0.0001
777 APPLICATION SITE ERYTHEMA 2 0.0001
778 JOINT STIFFNESS 2 0.0001
779 ANHEDONIA 2 0.0001
780 ANKYLOSING SPONDYLITIS 1 0.0001
781 OROPHARYNGEAL PAIN 7 0.0001
782 ADVERSE REACTION 1 0.0001
783 DRY SKIN 10 0.0001
784 NEOPLASM MALIGNANT 5 0.0001
785 HAIR TEXTURE ABNORMAL 1 0.0001
786 ANXIETY 21 0.0001
787 OEDEMA 4 0.0001
788 DRUG TOXICITY 1 0.0001
789 ACUTE HEPATIC FAILURE 1 0.0001
790 LUNG NEOPLASM MALIGNANT 3 0.0001
791 OSTEOPOROSIS 3 0.0001
792 CORONARY ARTERY OCCLUSION 1 0.0001
793 SKIN LESION 2 0.0001
794 PROCEDURAL PAIN 2 0.0001
795 ARTHROPATHY 4 0.0001
796 POLLAKIURIA 3 0.0001
797 HUNGER 1 0.0001
798 HAEMOPTYSIS 2 0.0001
799 APHONIA 1 0.0001
800 HOSPITALISATION 11 0.0001
801 PANCYTOPENIA 4 0.0001
802 DEMENTIA 2 0.0001
803 CARPAL TUNNEL SYNDROME 1 0.0001
804 INSOMNIA 19 0.0001
805 ALOPECIA 14 0.0001
806 BLOOD TEST ABNORMAL 1 0.0001
807 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
808 HYPONATRAEMIA 4 0.0001
809 OSTEOARTHRITIS 3 0.0001
810 FLATULENCE 4 0.0001
811 BRONCHOSPASM 1 0.0001
812 LETHARGY 4 0.0001
813 ACCIDENTAL UNDERDOSE 1 0.0001
814 ANOSMIA 1 0.0001
815 MYOCARDIAL INFARCTION 12 0.0001
816 MUSCULOSKELETAL STIFFNESS 6 0.0001
817 CHEST DISCOMFORT 7 0.0001
818 BONE PAIN 4 0.0001
819 DIARRHOEA 44 0.0001
820 ILLNESS 7 0.0001
821 ACUTE MYOCARDIAL INFARCTION 2 0.0001
822 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
823 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
824 RESPIRATORY DISORDER 2 0.0001
825 CORONARY ARTERY DISEASE 2 0.0001
826 DEVICE RELATED INFECTION 1 0.0001
827 FEMUR FRACTURE 2 0.0001
828 WHITE BLOOD CELL COUNT DECREASED 7 0.0001
829 NAUSEA 51 0.0001
830 COGNITIVE DISORDER 3 0.0001
831 SWELLING 6 0.0001
832 BASAL CELL CARCINOMA 1 0.0001
833 HEAD INJURY 2 0.0001
834 INFLUENZA 7 0.0001
835 MULTIPLE SCLEROSIS 3 0.0001
836 ABSCESS 1 0.0001
837 METABOLIC ACIDOSIS 2 0.0001
838 CONTUSION 6 0.0001
839 MOVEMENT DISORDER 2 0.0001
840 CARDIAC FAILURE 5 0.0001
841 NIGHT SWEATS 2 0.0001
842 ATRIAL FIBRILLATION 6 0.0001
843 SWELLING FACE 4 0.0001
844 PRODUCT DOSE OMISSION 4 0.0001
845 LUNG DISORDER 3 0.0001
846 CHOLELITHIASIS 2 0.0001
847 IMPAIRED HEALING 2 0.0001
848 INFLUENZA LIKE ILLNESS 5 0.0001
849 VIRAL INFECTION 2 0.0001
850 URINARY RETENTION 2 0.0001
851 FACE OEDEMA 1 0.0001
852 CANDIDA INFECTION 1 0.0001
853 FLUSHING 6 0.0001
854 THERAPY CESSATION 3 0.0001
855 HAEMATURIA 2 0.0001
856 INFLAMMATION 3 0.0001
857 WEIGHT INCREASED 13 0.0001
858 ARTHRALGIA 24 0.0001
859 EOSINOPHILIA 1 0.0001
860 INCORRECT DOSE ADMINISTERED 13 0.0001
861 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
862 DRUG ERUPTION 1 0.0001
863 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
864 CEREBRAL HAEMORRHAGE 2 0.0001
865 RASH PRURITIC 3 0.0001
866 INFECTION 8 0.0001
867 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
868 BONE DISORDER 1 0.0001
869 RESPIRATORY FAILURE 4 0.0001
870 END STAGE RENAL DISEASE 1 0.0001
871 SUICIDAL IDEATION 5 0.0001
872 HYPERHIDROSIS 7 0.0001
873 DYSURIA 2 0.0001
874 ANAPHYLACTIC REACTION 3 0.0001
875 TREMOR 9 0.0001
876 SEPSIS 6 0.0001
877 THROMBOCYTOPENIA 6 0.0001
878 ASTHMA 6 0.0001
879 INTESTINAL OBSTRUCTION 2 0.0001
880 FOOT FRACTURE 1 0.0001
881 BLOOD URINE PRESENT 1 0.0001
882 NEUROPATHY PERIPHERAL 5 0.0001
883 DIABETES MELLITUS 4 0.0001
884 HERPES ZOSTER 3 0.0001
885 INJECTION SITE SWELLING 4 0.0001
886 DRUG PRESCRIBING ERROR 1 0.0001
887 HERNIA 1 0.0001
888 EAR PAIN 1 0.0001
889 PLASMA CELL MYELOMA 2 0.0001
890 CHOKING 1 0.0001
891 VOMITING 24 0.0001
892 PARAESTHESIA 8 0.0001
893 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
894 INJECTION SITE BRUISING 4 0.0001
895 IRRITABILITY 3 0.0000
896 JOINT SWELLING 6 0.0000
897 ILL-DEFINED DISORDER 3 0.0000
898 FEEDING DISORDER 1 0.0000
899 BONE MARROW FAILURE 1 0.0000
900 ABDOMINAL PAIN 11 0.0000
901 HYPOACUSIS 2 0.0000
902 AMNESIA 3 0.0000
903 MENTAL DISORDER 2 0.0000
904 FEELING ABNORMAL 11 0.0000
905 LIVER DISORDER 2 0.0000
906 DEATH 38 0.0000
907 APPLICATION SITE PRURITUS 1 0.0000
908 HEPATIC ENZYME INCREASED 3 0.0000
909 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
910 ABDOMINAL PAIN UPPER 9 0.0000
911 SEIZURE 5 0.0000
912 BACK PAIN 10 0.0000
913 CARDIAC DISORDER 4 0.0000
914 INJURY 3 0.0000
915 CHILLS 5 0.0000
916 SLEEP DISORDER 3 0.0000
917 BLOOD GLUCOSE INCREASED 8 0.0000
918 DYSPHAGIA 4 0.0000
919 DISEASE RECURRENCE 2 0.0000
920 BLOOD GLUCOSE DECREASED 2 0.0000
921 DIABETIC KETOACIDOSIS 1 0.0000
922 UNDERDOSE 3 0.0000
923 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
924 UNEVALUABLE EVENT 3 0.0000
925 HAEMATEMESIS 1 0.0000
926 CARDIOVASCULAR DISORDER 1 0.0000
927 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
928 ABDOMINAL DISTENSION 4 0.0000
929 DERMATITIS ATOPIC 2 0.0000
930 PANCREATITIS 2 0.0000
931 THROMBOSIS 3 0.0000
932 DRUG EFFECT DECREASED 2 0.0000
933 DISTURBANCE IN ATTENTION 2 0.0000
934 OVERDOSE 8 0.0000
935 BLOOD BILIRUBIN INCREASED 1 0.0000
936 ANAEMIA 7 0.0000
937 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
938 ANGINA PECTORIS 1 0.0000
939 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
940 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
941 ASCITES 1 0.0000
942 DISEASE PROGRESSION 4 0.0000
943 GASTROINTESTINAL DISORDER 3 0.0000
944 BLOOD POTASSIUM DECREASED 1 0.0000
945 HEPATIC FAILURE 1 0.0000
946 APHASIA 1 0.0000
947 EMOTIONAL DISTRESS 4 0.0000
948 THERAPEUTIC RESPONSE DECREASED 2 0.0000
949 PLEURAL EFFUSION 2 0.0000
950 EPILEPSY 1 0.0000
951 INJECTION SITE PAIN 10 0.0000
952 DRUG ADMINISTRATION ERROR 1 0.0000
953 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
954 GYNAECOMASTIA 1 0.0000
955 BONE DENSITY DECREASED 1 0.0000
956 DRUG-INDUCED LIVER INJURY 1 0.0000
957 DRUG DOSE OMISSION 5 0.0000
958 DEVICE DIFFICULT TO USE 2 0.0000
959 FUNGAL INFECTION 1 0.0000
960 URTICARIA 5 0.0000
961 NEUTROPENIA 4 0.0000
962 GASTRIC DISORDER 1 0.0000
963 PLATELET COUNT DECREASED 3 0.0000
964 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
965 DRUG EFFECT INCOMPLETE 1 0.0000
966 CRYING 1 0.0000
967 HYPERGLYCAEMIA 1 0.0000
968 AGITATION 2 0.0000
969 HALLUCINATION 2 0.0000
970 COLITIS 1 0.0000
971 ACNE 2 0.0000
972 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
973 CARDIAC FAILURE CONGESTIVE 2 0.0000
974 RENAL IMPAIRMENT 2 0.0000
975 DEVICE LEAKAGE 1 0.0000
976 DEHYDRATION 3 0.0000
977 COMA 1 0.0000
978 AGGRESSION 1 0.0000
979 EXPOSURE DURING PREGNANCY 1 0.0000
980 PSORIASIS 2 0.0000
981 FEBRILE NEUTROPENIA 1 0.0000
982 RENAL FAILURE 2 0.0000
983 DEVICE MALFUNCTION 1 0.0000
984 CARDIAC ARREST 1 0.0000
985 TOXICITY TO VARIOUS AGENTS 2 0.0000
986 DRUG WITHDRAWAL SYNDROME 1 0.0000
987 DEVICE ISSUE 1 0.0000
988 BREAST CANCER 1 0.0000
989 DRUG DEPENDENCE 1 0.0000